Skip to main content
Year archive

Evotec SE — 2021 filings

All 105 regulatory filings released by Evotec SE (EVT) in 2021, sourced directly from the official regulator.

105 Filings
2021 Period
2021 filings (105)
Filing Released Lang
Evotec receives US$ 18 m grant for women's health
Capital/Financing Update
2021-12-16 English
Declaration of Corporate Management 2021
Governance Information
2021-12-01 English
Declaration of Compliance with the German Corporate Governance Code for the year 2021
Governance Information
2021-12-01 English
Entsprechenserklärung zum Deutschen Corporate Governance Kodex für das Jahr 2021
Governance Information
2021-12-01 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-11-22 English
Evotec and EQRx announce integrated drug discovery and development partnership
Regulatory Filings
2021-11-18 English
Q3 statement / Q3 financial report 2021
Interim / Quarterly Report 9M 2021
2021-11-12 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-11 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-11 English
Evotec SE reports results for the first nine months 2021 and provides corporate update
Earnings Release 9M 2021
2021-11-11 English
Präsentation Q3 2021
Investor Presentation 9M 2021
2021-11-11 English
Evotec reaches programme designations in neuroscience collaboration with Bristol Myers Squibb
Regulatory Filings
2021-11-10 English
Evotec SE announces closing of public offering
Share Issue/Capital Change
2021-11-09 English
Correction of a release from 05/11/2021, 15:48 CET/CEST - Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-11-08 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-08 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-11-05 English
Evotec SE Announces Placement of its Public Offering of American Depositary Shares
Capital/Financing Update
2021-11-04 English
EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2021 ON 11 NOVEMBER 2021
Report Publication Announcement
2021-11-03 English
Evotec SE: Announces launch of public offering of American Depositary Shares
Share Issue/Capital Change
2021-10-26 English
Evotec provides preliminary nine month financial results
Earnings Release 9M 2021
2021-10-26 English
Evotec SE files registration statement for proposed offering of American Depositary Shares
Capital/Financing Update
2021-10-11 English
Evotec expands neuroscience collaboration with Bristol Myers Squibb to include novel cell type
Regulatory Filings
2021-10-08 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-09-30 English
Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration
Regulatory Filings
2021-09-02 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-09-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-08-31 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-08-25 English
Half-yearly financial report 2021
Interim / Quarterly Report H1 2021
2021-08-12 German
Just - Evotec Biologics opens J.POD 1 US in Redmond, Washington
Regulatory Filings
2021-08-11 English
EVOTEC SE REPORTS FIRST HALF-YEAR 2021 RESULTS AND CORPORATE UPDATES
Earnings Release H1 2021
2021-08-11 English
Präsentation H1 2021
Investor Presentation H1 2021
2021-08-11 English
Evotec SE to announce results for the first half-year 2021 on 11 August 2021
Report Publication Announcement
2021-08-04 English
Evotec SE: Positive Phase IIb data for investigational P2X3 antagonist in patients with refractory chronic cough
Legal Proceedings Report
2021-08-03 English
Evotec SE Announces Confidential Submission of Draft Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission for a Proposed Offering of American Depositary Shares
Capital/Financing Update
2021-08-02 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-07-30 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-26 English
Evotec creates long-term growth opportunities by initiating 'Campus Levi-Montalcini' in Verona
Regulatory Filings
2021-07-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-06-30 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-25 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-21 English
Evotec SE virtual Annual General Meeting 2021 approves all proposed agenda items
AGM Information
2021-06-15 English
Evotec launches 'PRROTECT', a pre-competitive initiative to be better prepared for future pandemics
Environmental & Social Information
2021-06-15 English
Evotec Hauptversammlung 2021
AGM Information
2021-06-15 German
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-05-31 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-05-25 English
EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE
Earnings Release Q1 2021
2021-05-11 English
Präsentation Q1 2021
Investor Presentation Q1 2021
2021-05-11 English
Q1 Mitteilung / Q1 Finanzbericht 2021
Interim / Quarterly Report Q1 2021
2021-05-11 German
Q1 statement / Q1 financial report 2021
Interim / Quarterly Report Q1 2021
2021-05-11 English
Evotec SE: Bekanntmachung der Einberufung zur Hauptversammlung am 15.06.2021 in Hamburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2021-05-06 German
Evotec launches 'beLAB1407' to accelerate translational research from the UK's academic life science ecosystem in collaboration with Bristol Myers Squibb
Regulatory Filings
2021-05-06 English
Evotec SE to announce results for the first quarter 2021 on 11 May 2021
Earnings Release Q1 2021
2021-05-04 English
Evotec and the GCKD study enter into strategic collaboration to build a unique molecular patient database
Environmental & Social Information
2021-05-04 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-04-30 English
Bristol Myers Squibb exercises option to extend targeted protein degradation partnership with Evotec
M&A Activity
2021-04-26 English
Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
Board/Management Information
2021-04-23 English
Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse
Environmental & Social Information
2021-04-20 English
Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
M&A Activity
2021-04-19 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-04-14 English
Annual financial report 2020
Annual Report FY 2020
2021-04-14 English
Evotec launches 'beLAB2122', translating academic innovation from leading German life science region in collaboration with Bristol Myers Squibb
Legal Proceedings Report
2021-04-13 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-04-09 English
Evotec and Exscientia announce start of human clinical trials of novel immuno-oncology drug
Regulatory Filings
2021-04-09 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 English
EVOTEC SE FISCAL YEAR 2020 RESULTS: GAINING SPEED ON 'THE DATA-DRIVEN R&D AUTOBAHN TO CURES'
Earnings Release FY 2020
2021-03-25 English
Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance
Regulatory Filings
2021-03-22 English
Evotec SE to announce results for fiscal year 2020 on 25 March 2021
Report Publication Announcement
2021-03-18 English
Präsentation FY 2020
Investor Presentation
2021-03-16 English
Evotec and Chinook Therapeutics enter into strategic collaboration to discover and develop novel precision medicines for chronic kidney diseases
M&A Activity
2021-03-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-02-26 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-24 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-10 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-10 English
Evotec and Related Sciences enter integrated drug discovery and development partnership
Regulatory Filings
2021-02-09 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-05 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-04 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-04 English
Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure
M&A Activity
2021-02-04 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-01 English
Evotec CSO Cord Dohrmann Appointed to German Council of Science and Humanities
Board/Management Information
2021-02-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-01-29 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-01-29 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-01-29 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-01-29 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-01-29 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-01-29 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-01-28 English
Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation
Regulatory Filings
2021-01-28 English
Just - Evotec Biologics Expands Contract with the Department of Defense for Manufacturing of Monoclonal Antibodies
Legal Proceedings Report
2021-01-27 English
DGAP-DD: Evotec SE english
Director's Dealing
2021-01-26 English
Report Publication Announcement 2021
Report Publication Announcement
2021-01-19 English
Report Publication Announcement 2021
Report Publication Announcement
2021-01-19 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-01-07 English
EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES
Regulatory Filings
2021-01-07 English
EVOTEC ACHIEVES MILESTONE IN ITS NEURODEGENERATION COLLABORATION WITH BRISTOL MYERS SQUIBB
Regulatory Filings
2021-01-05 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-01-04 English